Keeler Thomas Management LLC Has $2.53 Million Stake in Synopsys, Inc. $SNPS

Keeler Thomas Management LLC lifted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 37.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,129 shares of the semiconductor company’s stock after purchasing an additional 1,392 shares during the period. Synopsys makes up about 1.0% of Keeler Thomas Management LLC’s investment portfolio, making the stock its 25th biggest position. Keeler Thomas Management LLC’s holdings in Synopsys were worth $2,531,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Alpine Bank Wealth Management raised its position in shares of Synopsys by 89.3% in the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after buying an additional 25 shares in the last quarter. TFC Financial Management Inc. increased its stake in Synopsys by 1,250.0% in the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock valued at $27,000 after purchasing an additional 50 shares in the last quarter. Millstone Evans Group LLC acquired a new position in shares of Synopsys during the third quarter worth approximately $27,000. SOA Wealth Advisors LLC. bought a new stake in shares of Synopsys during the third quarter worth about $28,000. Finally, McIlrath & Eck LLC purchased a new stake in shares of Synopsys in the third quarter valued at about $29,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Insider Activity

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Janet Lee sold 250 shares of the business’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the transaction, the insider directly owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 4,157 shares of company stock worth $1,945,036. Insiders own 0.62% of the company’s stock.

Wall Street Analyst Weigh In

SNPS has been the subject of several research reports. Rosenblatt Securities upgraded Synopsys from a “neutral” rating to a “buy” rating and cut their price target for the stock from $605.00 to $560.00 in a research note on Tuesday, December 9th. Morgan Stanley lifted their price objective on shares of Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Wells Fargo & Company raised their price target on shares of Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a research note on Thursday, December 11th. JPMorgan Chase & Co. boosted their price target on shares of Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a research note on Thursday, December 11th. Finally, Zacks Research raised shares of Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Synopsys presently has an average rating of “Moderate Buy” and an average target price of $553.57.

Synopsys Trading Down 1.6%

SNPS opened at $457.89 on Tuesday. The stock’s fifty day moving average is $478.60 and its two-hundred day moving average is $500.20. The company has a market capitalization of $87.60 billion, a P/E ratio of 57.31, a PEG ratio of 3.87 and a beta of 1.12. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48.

Synopsys (NASDAQ:SNPS) last released its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.25 billion. During the same quarter in the previous year, the company earned $3.40 earnings per share. The company’s quarterly revenue was up 37.8% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.